Enlight Renewable Energy Ltd. has announced that it will hold its Annual General Meeting (AGM) of shareholders on December 9, 2026. This meeting is significant as it will address several important proposals that could shape the future of the company.
The AGM is set to take place at 4:00 p.m. Israel time at the company’s offices located in Rosh Ha’ayin, Israel. Shareholders will have the opportunity to vote on critical matters, including the re-appointment of Somekh Chaikin, a member firm of KPMG International, as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Additionally, the meeting will include elections for board members, with nominees including Mr. Gilad Yavetz, Mr. Yair Seroussi, Ms. Liat Benyamini, Ms. Michal Tzuk, Ms. Alla Felder, Dr. Shai Weil, Mr. Yitzhak Betzalel, and Mr. Zvi Furman. Each nominee is expected to hold office until the next annual general meeting in 2027.
Shareholders who are on record as of November 2, 2026, will be entitled to vote at the meeting. The company has indicated that the audited consolidated financial statements for the fiscal year ending December 31, 2025, will also be presented for discussion during the AGM.
This filing, accession number 0001178913-26-004861, highlights the importance of shareholder engagement and governance in the electric services industry, where Enlight operates. The outcomes of this meeting could have implications not only for the company but also for its stakeholders and competitors.
As the AGM approaches, Enlight Renewable Energy Ltd. encourages shareholders to participate actively, whether in person or by proxy, to ensure their voices are heard in shaping the company’s governance.
Read Next
Sweet Julie Spellman acquires 12,200 shares of Accenture
Putnam ETF Trust Files Certified Shareholder Report
UBS Group AG releases third quarter 2026 financial results
Banco Santander Reports Financial Results for 2026 Q3
Nationwide Fund Advisors reveals Q3 2026 investment portfolio
UBS Group AG discloses Q3 2026 capital instruments details










